메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Alansari Shahad (Department of Pediatric Rheumatology King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia) Alsaleem Alhanouf (Department of Pediatric Rheumatology King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia) Alzaid Tariq (Department of Pathology and Laboratory Medicine King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia) Galal Maad (Department of Pediatrics College of Medicine Alfaisal University Riyadh Saudi Arabia) Alyahya Noura (Department of Pediatric Rheumatology King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia) Al-Mayouf Sulaiman M (Department of Pediatric Rheumatology King Faisal Specialist Hospital and Research Center Riyadh Saudi ArabiaDepartment of Pediatrics College of Medicine Alfaisal University Riyadh Saudi Arabia)
저널정보
대한류마티스학회 대한류마티스학회지 대한류마티스학회지 제30권 제2호
발행연도
2023.4
수록면
133 - 137 (5page)
DOI
10.4078/jrd.22.0054

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Genetic defects of SLC29A3 result in a wide range of syndromic histiocytosis that encompasses H syndrome. Patients with SLC29A3 variants typically have hyperpigmentation, hypertrichosis, hepatosplenomegaly, sensorineural hearing loss, diabetes mellitus, and hypogonadism. Herein, we identify a novel phenotype in a girl presenting with clinical and laboratory findings similar to systemic juvenile arthritis and hyperferritinemia. Exome sequencing identified a homozygous variant in SLC29A3 (NM_018344.5: c.707C>T [p.T236M]). Our patient did not show the cardinal features of the broad spectrum of SLC29A3 -related disorders. She demonstrated remarkable improvement in her clinical and laboratory manifestations after starting interleukin-1 blockade (Anakinra). Recent research suggests that SLC29A3 -related disorders are accompanied with autoinflammation and autoimmunity due to an overactive inflammasome pathway, which is most likely induced by mitochondrial and lysosomal dysfunction. Hence, our findings may expand the phenotypic features of the SLC29A3 variant. Patients with the SLC29A3 variant and systemic inflammation may benefit from interleukin-1 blockade as a therapeutic option.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0